Literature DB >> 2894612

Identification and characterization of E. coli type-1 pilus tip adhesion protein.

M S Hanson1, C C Brinton.   

Abstract

The type-1 pilus of Escherichia coli is the prototype of this class of hair-like, multimeric adhesive organelles. This pilus mediates adherence to mannose-containing receptors on mucosal epithelia and other cells. The type-1 pilus, in one of several serological variants, is expressed by nearly all E. coli strains, and its promotion of colonization by pathogenic bacteria and the protective effects of purified pilus vaccines suggest that it is important as a bacterial virulence factor. Both the adhesive function and the serological variation of the type-1 pilus have been attributed to the thousand or so pilin protein monomers making up the pilus rods. This idea has been contradicted by our earlier observations on an E. coli strain expressing adhesion-defective pili. More recent genetic evidence also indicates that auxiliary pilus proteins are required for adhesive function. We report here the identification of three previously undetected integral minor proteins on the type-1 pilus, and show that one of them is the receptor-binding adhesin. This protein is antigenically conserved among strains with different pilin serotypes and is located at the pilus tip.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2894612     DOI: 10.1038/332265a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  66 in total

1.  T-cell-independent stimulation of immunoglobulin secretion in resting human B lymphocytes by the mannose-specific adhesin of Escherichia coli type 1 fimbriae.

Authors:  S Ponniah; S N Abraham; R O Endres
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

2.  Genetic control of flocculation in Escherichia coli.

Authors:  K L Ogden; A L Taylor
Journal:  J Ind Microbiol       Date:  1991-06

Review 3.  Molecular biology and respiratory disease. 6. Modern molecular biology and respiratory bacterial infections: a revolution on the horizon.

Authors:  T F Murphy
Journal:  Thorax       Date:  1990-07       Impact factor: 9.139

4.  Escherichia coli K1 RS218 interacts with human brain microvascular endothelial cells via type 1 fimbria bacteria in the fimbriated state.

Authors:  Ching-Hao Teng; Mian Cai; Sooan Shin; Yi Xie; Kee-Jun Kim; Naveed Ahmed Khan; Francescopaolo Di Cello; Kwang Sik Kim
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

5.  Analysis of colonization factor antigen I, an adhesin of enterotoxigenic Escherichia coli O78:H11: fimbrial morphology and location of the receptor-binding site.

Authors:  T Bühler; H Hoschützky; K Jann
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

6.  Identification, characterization, and nucleotide sequence of the F17-G gene, which determines receptor binding of Escherichia coli F17 fimbriae.

Authors:  P F Lintermans; A Bertels; C Schlicker; F Deboeck; G Charlier; P Pohl; M Norgren; S Normark; M van Montagu; H De Greve
Journal:  J Bacteriol       Date:  1991-06       Impact factor: 3.490

7.  Effects of ompA deletion on expression of type 1 fimbriae in Escherichia coli K1 strain RS218 and on the association of E. coli with human brain microvascular endothelial cells.

Authors:  Ching-Hao Teng; Yi Xie; Sooan Shin; Francescopaolo Di Cello; Maneesh Paul-Satyaseela; Mian Cai; Kwang Sik Kim
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

8.  Specificity of the high-mannose recognition site between Enterobacter cloacae pili adhesin and HT-29 cell membranes.

Authors:  Y T Pan; B Xu; K Rice; S Smith; R Jackson; A D Elbein
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

9.  Type 1 fimbriation and its phase switching in diarrheagenic Escherichia coli strains.

Authors:  K Iida; Y Mizunoe; S N Wai; S Yoshida
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

10.  HbiF regulates type 1 fimbriation independently of FimB and FimE.

Authors:  Yi Xie; Yufeng Yao; Vitaliy Kolisnychenko; Ching-Hao Teng; Kwang Sik Kim
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.